News

Press Releases

Asuragen Launches Assay to Aid in the Diagnosis of Myotonic Dystrophy Type I (DM1)
Asuragen Announces Health Canada Approval of the QuantideX® qPCR BCR-ABL IS Kit
Asuragen to Present at 2018 Association for Molecular Pathology (AMP) Annual Meeting
New laboratory screening test for fragile X syndrome shortly after birth now ready for pivotal North Carolina Early Check clinical study
Asuragen Announces New Commercial Leadership Appointment
Asuragen to Present at 2018 American Society of Human Genetics Annual Meeting
Asuragen to Host Panel at Upcoming World Clinical Biomarkers & Companion Diagnostic Summit
Asuragen Expands Oncology Portfolio with CE Marking and Launch of QuantideX® NGS DNA Hotspot 21 Kit
Asuragen Expands AmplideX® Technology and Product Line with Launch of PCR/CE SMN1 Kit
Asuragen to Launch the AmplideX® PCR/CE DMPK Kit and Present Growing Genetic Testing Portfolio at 2018 European Society of Human Genetics (ESHG) Conference

About

Back To
Top

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close